A new case of homozygous C1-inhibitor deficiency suggests a role for Arg378 in the control of kinin pathway activation.

[1]  H. Longhurst,et al.  Clinical Immunology Review Series: An approach to the patient with angio‐oedema , 2009, Clinical and experimental immunology.

[2]  M. Cicardi,et al.  C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. , 2009, Trends in molecular medicine.

[3]  M. Cicardi,et al.  Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation. , 2008, Autoimmunity reviews.

[4]  M. López-Trascasa,et al.  First case of homozygous C1 inhibitor deficiency. , 2006, The Journal of allergy and clinical immunology.

[5]  F. Callea,et al.  Differential detection of PAS‐positive inclusions formed by the Z, Siiyama, and Mmalton variants of α1‐antitrypsin , 2004, Hepatology.

[6]  M. Cicardi,et al.  Increased expression of C1-inhibitor mRNA in patients with hereditary angioedema treated with Danazol. , 2003, Immunology letters.

[7]  G. Milon,et al.  In Vivo Biosynthesis of Endogenous and of Human C1 Inhibitor in Transgenic Mice: Tissue Distribution and Colocalization of Their Expression1 , 2002, The Journal of Immunology.

[8]  A. Davis,et al.  Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: inhibition of complement and contact system proteases. , 1997, Journal of immunology.

[9]  J. Bissler,et al.  Unique C1 inhibitor dysfunction in a kindred without angioedema. II. Identification of an Ala443-->Val substitution and functional analysis of the recombinant mutant protein. , 1995, The Journal of clinical investigation.

[10]  E. Verpy,et al.  COOH-terminal Substitutions in the Serpin C1 Inhibitor That Cause Loop Overinsertion and Subsequent Multimerization (*) , 1995, The Journal of Biological Chemistry.

[11]  D. Dearborn,et al.  Unique C1 inhibitor dysfunction in a kindred without angioedema. I. A mutant C1 INH that inhibits C1-s but not C1-r. , 1994, Journal of immunology.

[12]  C. Hack,et al.  Inactivation of C-1 inhibitor by proteases: demonstration by a monoclonal antibody of a neodeterminant on inactivated, non-complexed C-1 inhibitor. , 1987, Immunology.

[13]  D. Alling,et al.  Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. , 1976, The New England journal of medicine.